Fermer le menu


Member of Lyonbiopole


The Pharmaceutical Company that's Bringing out the Next Generation of Dermal Fillers. Here at Bioxis Pharmaceuticals, we have created biomaterial scaffolds that help regenerate tissues, improve patient outcomes, and provide better healthcare opportunities for doctors. We are focused on developing medical devices based on patented biomaterials technology with potentially accelerated pathways to market.

Our lead medical device candidate MTI-12 is currently at the pre-clinical stage for aesthetic indications; and our hyaluronic acid-based dermal filler brand, CYTOSIAL, has established into exclusive distribution agreements with distributors in Europe and Asia.                          



Strategic application domain: Medical Technologies

Application market: Dermatology & Cosmetology

Type of activity: Medical device, Technology provider

Technologies: Biomaterials, Regenerative medicine

Created on sept. 13th, 2010 - 20 employees



317 avenue Jean Jaures 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.